Summary
For Year 2025-26, Medicamen Organics reports the following shareholding: Total Promoters at 59.73%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.07%, Domestic Institutional Investors at 3.69%, and Retail at 36.51%. This breakdown provides a quick snapshot of ownership distribution for Medicamen Organics in 2025-26.
Medicamen Organics FAQs
As of 03-2026, the promoter shareholding in Medicamen Organics stands at 59.73% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Medicamen Organics is 0.07% and 3.69% respectively.
The retail shareholding of the Medicamen Organics is 36.51%.
Changes in shareholding patterns of Medicamen Organics can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Medicamen Organics are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
